Abstract. The development of cervical cancer exhibits some unique differences compared to other solid tumors. Normal cervical stratified epithelia have characteristics of hypoxic tissue. Lack of oxygen (hypoxia) induces the HIF-1 (hypoxiainducible factor-1) transcription factor, which is a heterodimer composed of a constitutively expressed β subunit and a hypoxia-inducible α-subunit. HIF-1A targets the transcription of over 70 genes involved in many aspects of cancer biology. In well-oxygenated environments, the HIF-1A subunit is hydroxylated, recognized and marked for proteosomal destruction by an E3 ubiquitin ligase, the von Hippel-Lindau protein (pVHL) complex. Under hypoxic stress, proline hydroxylase (PHD) activity is diminished, and stabilized HIF-1A is involved in the activation of the tissue response to hypoxia. Here, we examined the HIF-1A and VHL transcript levels and HIF-1A protein levels in cancerous tissue (n=30) and non-cancerous, normal uterine cervical tissue (n=30). We also compared the methylation status of HIF-1A and of the VHL promoter regions in cancerous and normal tissue samples. Significantly higher levels of HIF-1A and VHL transcripts (p<0.0001 and p= 0.0042, respectively) and of HIF-1A protein (p= 0.0037) were detected in cancerous tissue compared to normal samples. We did not observe DNA methylation in the HIF-1A and VHL promoter region in either control or cancerous tissue samples. VHL has a functional hypoxia response element (HRE) in the promoter region, and the induction of this HRE acts within a negative feedback loop to limit the hypoxic HIF-1A response. Our findings may suggest that HIF-1A could promote its own degradation by the induction of VHL gene expression (Spearman correlation coefficient, 0.515; p=0.003). Our study shows for the first time that this increase in VHL expression could be HIF-1A-dependent and serves within a negative feedback pathway during hypoxia to regulate the cell-specific oxygen threshold for HIF-1A activation.
Introduction
Cervical cancer is a significant cause of death in women worldwide and remains one of the most common cancers in women in developing countries (1) . The main histological type is squamous cell carcinoma, which accounts for approximately two-thirds of all cervical cancer cases, whereas adenocarcinoma and adenosquamous carcinomas account for 10-25% of cases (1) . The primary etiological factor associated with cervical cancer development is exposure to human papillomavirus (HPV), particularly types 16 and 18 (2) . Despite a relatively high prevalence of HPV in the cervix, the development of cervical cancer occurs after a long period of viral persistence. This suggests that additional genetic and epigenetic alterations as well as other factors may be required to maintain a malignant phenotype in the cervix (3) .
Human solid tumors contain hypoxic regions that have a considerably lower oxygen tension than healthy tissues (4) . Lack of oxygen (hypoxia) is a hallmark of solid tumor formation and constitutes an independent prognostic factor in a diverse range of malignant tumors (5) . Hypoxia induces hypoxia-inducible factor-1 (HIF-1), which has been identified as an important transcription factor that mediates the cellular response to hypoxia. HIF-1 protein is a heterodimer composed of a constitutively expressed β subunit (ARNT, aryl hydrocarbon receptor nuclear translocator) and a hypoxia-inducible α-subunit (HIF-1A) (6) . In well-oxygenated environments, HIF-1A subunits are hydroxylated at the conserved proline Pro 402 and Pro 564 residues. These modifications are mediated by proline hydroxylases (PHDs), whose activities are regulated by O 2 availability (7). Hydroxylated HIF-1A is, in turn, recognized and marked for proteosomal destruction by an E3 ubiquitin ligase, the von Hippel-Lindau protein (pVHL) complex (8) . Under hypoxic stress, PHD activity is diminished, and stabilized HIF-1A is involved in the activation of numerous cellular processes including resistance to apoptosis, overexpression of several glycolytic protein and drug efflux membrane pumps, vascular remodeling, angiogenesis, and even metastasis (9,10). Furthermore, tumoral HIF-1A overexpression is often associated with poor prognosis and is observed in a vast number of solid tumors (11) (12) (13) (14) (15) . On the other hand, inhibition of HIF-1A by means of RNA interference or pharmacological compounds has demonstrable antitumoral efficacy in various murine cancer models (16) . However, the underlying molecular mechanisms of, as well as the role of HIF-1A in, drug resistance under normoxic conditions remain largely elusive (6) . Here, we studied the expression of HIF-1A (transcript and protein level) in cancerous tissue (n=30) and non-cancerous (normal) uterine cervical tissue (n=30) from a Polish cohort. We also compared, in cancerous and non-cancerous tissues, the VHL transcript level and the methylation status of HIF-1A and VHL promoter regions. (18) . RNA integrity was confirmed by denaturing agarose gel electrophoresis, and the concentration was quantified by measuring the optical density (OD) at 260 nm. RNA samples were treated with DNase I and reverse-transcribed into cDNA using oligo-dT primers.
Materials and methods
RQ-PCR was conducted in a real-time PCR-CFX96 detection system Bio-Rad Laboratories (CA, USA) using iQ SYBR-Green as detection dye, and target cDNA was quantified by a relative quantification method using a calibrator. For the calibrator, 1 µl of cDNA from all samples were mixed together. To create a standard curve, successive dilutions were used as described in the Relative Quantification Manual Roche Diagnostics GmbH (Mannheim, Germany). The quantity of HIF-1A and VHL transcripts in each sample was standardized by the PBGD transcript level. For amplification, 1 µl of total (20 µl) cDNA solution was added to 5 µl of iQ SYBR-Green Supermix (Bio-Rad Laboratories) and primers for HIF-1A, VHL and PBGD transcripts (Table ΙΙ) . One RNA sample of each preparation was processed without RT-reaction to provide a negative control in subsequent PCR.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis.
Normal and cancerous tissue samples were treated with the RIPA lysis buffer. Protein concentration was quantified using Bradford method according to manufacturer protocol (Bio-Rad Laboratories GmbH, Munich, Germany). Next, 30 µg of protein were resuspended in sample buffer and separated on 10% Tris-glycine gel using SDS-PAGE. Gel proteins were semi-dry transferred to PVDF membranes (Roche Diagnostics, Mannheim, Germany), which were blocked with 5% milk in Tris-buffered saline/Tween. Immunodetection was performed with anti-HIF-1A antibody (H-206), followed by incubation with the goat anti-rabbit IgG-HRP-conjugated antibody. As a loading control, the blots were stripped and reprobed with a goat anti-actin HRP-conjugated antibody (clone I-19). Bands were revealed using the SuperSignal West Femto Maximum Sensitivity Substrate Pierce (Rockford, IL) and Hyperfilm ECL Amersham (Piscataway, NJ).
Sodium bisulfite DNA sequencing of the HIF-1A and VHL promoter region. Genomic DNA from normal and cancerous tissues was extracted using a salting-out method. Extracted DNA was treated using the EZ DNA Methylation Kit™ (Zymo Research Corp., Orange, CA), according to the manufacturer's protocol. The location of the CpG islands in the promoter regions of HIF-1A and VHL genes were determined by an online program found at http://www.ebi.ac.uk/emboss/cpgplot/. The promoter regions containing CpG islands were amplified by the primer pairs (Table II) complementary to the modified DNA. PCR amplification was conducted by the FastStart Taq DNA Polymerase from Roche Diagnostic GmbH, (Penzberg, Germany). The PCR products were purified using the Agarose Gel DNA Extraction Kit (Roche) and cloned into the pGEM-T Easy Vector System I (Promega, Madison, WI) following transformation into TOPO10 E. coli strain cells. Plasmid DNA isolated from ten positive bacterial clones was used for commercial sequencing of the cloned fragments of DNA.
Statistical analysis. Data groups for cell lines were assessed by ANOVA to evaluate if there was significant differences (p<0.05) between the groups. For all experimental groups, which fulfilled the initial criterion, individual comparisons were performed by the post-hoc Tukey test with the assumption of a two-tailed distribution and two samples with equal variance at the p<0.05 level. The normality of the observed patient data distribution was assessed by the Shapiro-Wilk test and the unpaired, twotailed t-test was used to compare the mean values. p<0.05 was considered statistically significant. Spearman's rank correlation was used to determine whether a correlation between the expression of the analyzed genes was positive or negative.
Results
Increased HIF-1A expression in advanced uterine cervical carcinoma induces expression of VHL and is not associated with epigenetic regulation. RQ-PCR and Western blot analysis were used to compare HIF-1A and VHL transcript and HIF-1A protein levels in normal and cancerous tissues. Our results show significantly higher levels of HIF-1A and VHL transcript (p<0.0001 and p=0.0042, respectively) and HIF-1A protein (p= 0.0037) levels in cancerous tissue compared to normal tissue samples (Fig. 1A , B, and D; Table III ). We did not find significant differences between transcript and protein levels between patient groups with different tumor stage and histological grade. We also did not observe DNA methylation in the HIF-1A and VHL promoter region in either control or cancerous tissues samples (results not shown). A statistically significant association was found between HIF-1A and VHL expression (Spearman correlation coefficient=0.515, p=0.003).
Discussion
Cervical cancer exhibits some unique characteristics that are different from other solid tumors. Healthy stratified epithelia, including cervical cells, have characteristics of chronically hypoxic tissue (19) (20) (21) . Increased vascularity is observed in low grade cervical cancer, while this is usually a late event in the progression of many other cancers (20, 22) . Tissue hypoxia is a common feature of most solid tumors (15, 23, 24) , often with heterogeneous O 2 levels within different regions of the individual tumors. The cellular adaptation to hypoxic The target mRNA levels were corrected to the amount of PBGD cDNA and expressed as multiplicity of these cDNA copies in the calibrator. b The amount of Western blot-detected proteins was presented as the HIF-1A-to-β-actin band optical density ratio.
Normal tissue Cancerous tissue ---------------------------------------------------------------------------------------------------------------------------------------------------------
c Unpaired, two-tailed t-test.
stress is highly complex and depends on the up-regulation of genes supporting anaerobic metabolism and new blood vessel recruitment (25) . Under hypoxic conditions, cells secrete a variety of cytokines and growth factors that induce proliferation, migration, and blood vessel formation by endothelial cells (26) . The cellular response to hypoxia is primarily regulated through the activity of the HIF-1 (27) transcriptional factor, which targets the transcription of over 70 genes (28) . Other factors independent of hypoxia can also promote HIF-1A protein accumulation via translational or post-translational mechanisms (28) . Several studies have shown that many human cancers express an elevated level of HIF-1A protein, which is closely associated with a more aggressive tumor phenotype (29) (30) (31) (32) and offers resistance to radiotherapy and anticancer chemotherapy (33, 34) .
Rapid degradation of the ubiquitinated HIF-1A is considered the principal mechanism through which HIF-dependent transcription is suppressed during normoxia. The inhibition of PHDs activity due to decreased oxygen levels is considered critical for HIF-1A escape from proteosome degradation during hypoxia because the affinity of VHL for the non-hydroxylated HIF-1A is much lower (35) (36) (37) . Our previous research and that published by Roszak et al (38) show for the first time a full analysis of the hypoxia pathway in primary advanced uterine cervical carcinoma.
Normal cervical tissue has characteristics of hypoxic tissue (19-21) with partial stabilization of HIF-1A protein. This stabilization increases during carcinogenesis and the progression of cervical cancer. Fujimoto et al (39) reported that HIF-1A mRNA levels increase significantly with increasing disease stage. Similar data was presented by No et al (40) using the immunohistochemical method and paraffin-embedded specimens. HIF-1A expression was higher in cervical intraepithelial neoplasia and invasive cancer as compared to the corresponding normal uterine cervical tissues (40) .
Overexpression of HIF-1A was described in many solid tumors such as gastric (23), gallbladder (24) , colon, breast, lung, skin, ovarian, pancreatic, prostate and renal carcinoma (15) . High expression of HIF-1A was also reported in cervical cancer tissue samples (21, (39) (40) (41) (42) (43) (44) (45) (46) (47) , but only using the immunohistochemical method.
Furthermore, increased expression of HIF-1A is associated with low oxygen partial pressure (pO 2 ) in tissue samples. Hutchison et al (44) and Haugland et al (46) found significant correlations between immunohistochemically detected HIF-1A and low pO 2 in a group of 72 and 42 patients, respectively, with cervical carcinoma. Similarly, correlation between low pO 2 and high immunohistochemically detected HIF-1A was also described in advanced head and neck cancer (48) . Decreased pO 2 in cancerous tissue favors HIF-1A accumulation during hypoxia because PDH2 expression is depleted at low oxygen levels (38) .
We are the first to analyze HIF-1A transcript and protein levels in groups of patients with primary advanced uterine cervical carcinomas and normal, healthy uterine cervical tissues. We found a significantly increased level of HIF-1A and VHL transcripts (Fig. 1A and D respectively, Table III) in advanced uterine cervical carcinomas as compared to the corresponding normal uterine cervical tissues. A similar correlation was found in HIF-1A protein levels detected using Western blot technique in tumor tissue samples and their normal, non-cancerous counterpart ( Fig. 1B and C ; Table III) .
To date, expression of the VHL gene had not been reported in cervical cancer. The levels of the VHL transcript are increased in cervical carcinoma, which is the opposite of the demonstrated lower expression of VHL in renal cell carcinoma (49) , multiple myeloma (50), pancreatic endocrine tumors (51), chronic lymphocytic leukemia (52) and squamous cell carcinoma of the vulva (53) . The observed abnormal expression of VHL in cervical cancer could be associated with increased levels of HIF-1A, because we found a statistically significant, positive Spearman's rank correlation between HIF-1A and VHL expression.
Renbaum et al (54) were the first to report that the VHL 3'-untranslated region contains consensus HIF-1 binding sites. Blagosklonny (55) suggested the ability of the HIF-1 transcription factor to transactivate the VHL gene, which would establish a feedback loop. Finally, Karhausen et al (56) reported the induction of VHL gene expression by HIF-1A transcription factor in the HeLa cervical cancer cell line. These authors documented the direct HIF-1A binding to the VHL promoter and identified a functional hypoxia response element (HRE) within the VHL promoter. These results implicate a physiologically relevant feedback mechanism whereby HIF self-regulates its expression through VHL (56) . Our findings may suggest that HIF-1A could promote its degradation by the induction of VHL gene expression and could also be a first step to prove Blagosklonny's (55) hypothesis at the patient level in cervical cancer.
Referring to Pescador et al (57) and Metzen et al (58) , prolyl hydroxylases (PHD3 and PHD2) have a functional HRE in their promoter region, and its induction acts within a negative feedback loop to limit the hypoxic HIF-1 response. Henze et al (59) reported that PHD2 and PHD3 were induced by hypoxia in human glioblastomas and that PHDs protect against hypoxiainduced cell death. Ginouves et al (60) provided evidence that the hypoxic PHDs accumulation in human fibrosarcoma, breast and colon cancer cell lines, primary cultures of human dermal fibroblasts and human epidermal keratinocytes and in the animal, murine model, acts within a negative feedback loop to limit the HIF-1 response during conditions of reduced oxygen availability. A direct, negative regulatory mechanism, which limits accumulation of HIF-1A in hypoxia through induction of PHDs, has been reported by several investigators (61) (62) (63) (64) (65) (66) (67) . In our previously published report (38) we found significantly lower levels of PHD2 transcript and protein levels in cancerous tissue than in the corresponding normal tissue. We did not observe a negative feedback loop to limit HIF-1 via induction of PHDs. We can explain this result by analyzing the promoter region of PHD2. The majority of the HREs of hypoxia induced genes contains a HIF-1 ancillary sequence (HAS), which is located 8-9 nucleotides down-or upstream of hypoxia binding sites and is necessary for HIF-1A mediated transcription activation (68) . Furthermore, efficient gene activation requires recruiting of additional transcriptional factors, such as ATF-1/CREB-1, AP-1 and HNF-4 factor (69), which are not hypoxia dependent. Wenger et al (28) also reported that nucleotides located close to HRE in the promoter sequence can also affect HIF-1 gene activation. Therefore, mutations present in the promoter region of the PHD2 gene could perturb the negative feedback loop of the hypoxia pathway. We found single nucleotide mutations in the PHD2 promoter, which normally provides binding sites for transcription factors (38) . These mutations may remove binding sites for transcription factors, which are required for hypoxia HIF-1A induced expression (69) of PHD2.
In conclusion, we demonstrate increased HIF-1A, VHL transcript and HIF-1A protein levels in advanced uterine cervical carcinoma. We also observe that the increase in VHL expression could be HIF-1A-dependent and serves within a negative feedback pathway during hypoxia to regulate the cell-specific oxygen threshold for HIF-1A activation. However, further studies are required to elucidate the negative feedback pathways in cervical cancer.
